Literature DB >> 24179916

OXA-181 Beta Lactamase is not a Major Mediator of Carbapenem Resistance in Enterobacteriaceae.

M Shanthi1, Uma Sekar, Arunagiri K, Hemant Goverdhandas Bramhne.   

Abstract

BACKGROUND: Detection of carbapenem hydrolyzing class D beta lactamase OXA-181, (a variant of OXA-48) in Enterobacteriaceae, is important, to institute appropriate therapy and to initiate preventive measures. This study was done to determine the presence of OXA 48 and its derivative OXA-181 in Enterobacteriaceae of pathogenic significance.
MATERIAL AND METHODS: One hundred and eleven non-repetitive Enterobacteriaceae isolates which were resistant to any of the cephalosporin subclasses III and which exhibited reduced susceptibility to carbapenems were included in the study. Minimum inhibitory concentrations (MICs) to imipenem and meropenem was determined by broth microdilution. Production of carbapenamase was screened by Modified Hodge test (MHT). Polymerase Chain Reaction (PCR) was done to detect the presence of bla OXA-181 and bla OXA-48 .Coexistence of other carbapenemase encoding genes, namely, NDM-1, VIM, IMP and KPC were also looked for, by PCR.
RESULTS: Of all the isolates which were tested, only 2 (1.8%) revealed the presence of OXA-181 and OXA-48. These were Klebsiella pneumoniae and Citrobacter freundii. MICs of imipenem and meropenem for Klebsiella pneumoniae were 128mg/l and 64 mg/l and for Citrobacter freundii, they were 32mg/l and 16mg/l respectively. MHT was positive in both isolates.
CONCLUSION: Production of OXA-48 / OXA-181 is not a major mechanism of carbapenem resistance. PCR is the gold standard for its routine identification in clinical microbiology laboratory.

Entities:  

Keywords:  Enterobacteriaceae; OXA-181 carbapenemase; Polymerase chain reaction

Year:  2013        PMID: 24179916      PMCID: PMC3809655          DOI: 10.7860/JCDR/2013/5884.3379

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.

Authors:  Laurent Poirel; Alain Ros; Anne Carricajo; Philippe Berthelot; Bruno Pozzetto; Sandrine Bernabeu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

2.  Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Dilip Mathai; Jan M Bell; Ronald N Jones; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

3.  Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK.

Authors:  Vassiliki Dimou; Hiran Dhanji; Rachel Pike; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2012-04-24       Impact factor: 5.790

4.  Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.

Authors:  Caroline Dallenne; Anaelle Da Costa; Dominique Decré; Christine Favier; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

5.  Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae.

Authors:  Anaïs Potron; Patrice Nordmann; Emilie Lafeuille; Zaina Al Maskari; Fatma Al Rashdi; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

6.  Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands.

Authors:  Jayant S Kalpoe; Nashwan Al Naiemi; Laurent Poirel; Patrice Nordmann
Journal:  J Med Microbiol       Date:  2011-01-20       Impact factor: 2.472

Review 7.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

8.  Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak.

Authors:  José Ramón Paño-Pardo; Guillermo Ruiz-Carrascoso; Carolina Navarro-San Francisco; Rosa Gómez-Gil; Marta Mora-Rillo; María Pilar Romero-Gómez; Natalia Fernández-Romero; Julio García-Rodríguez; Verónica Pérez-Blanco; Francisco Moreno-Ramos; Jesús Mingorance
Journal:  J Antimicrob Chemother       Date:  2012-10-07       Impact factor: 5.790

9.  Tigecycline susceptibility report from an Indian tertiary care hospital.

Authors:  Bijayini Behera; Anupam Das; Purva Mathur; Arti Kapil; Ravisekhar Gadepalli; Benu Dhawan
Journal:  Indian J Med Res       Date:  2009-04       Impact factor: 2.375

10.  Carbapenem-hydrolyzing oxacillinase-48 and oxacillinase-181 in Canada, 2011.

Authors:  Laura F Mataseje; David A Boyd; Linda Hoang; Miguel Imperial; Brigitte Lefebvre; Mark Miller; Susan M Poutanen; Diane Roscoe; Barbara M Willey; Michael R Mulvey
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

View more
  8 in total

1.  A Cost-Effective Method for Identifying Enterobacterales with OXA-181.

Authors:  Gisele Peirano; Yasufumi Matsumura; Diego Nobrega; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

2.  Act Fast as Time Is Less: High Faecal Carriage of Carbapenem-Resistant Enterobacteriaceae in Critical Care Patients.

Authors:  Sanjith Saseedharan; Manisa Sahu; Edwin Joseph Pathrose; Sarita Shivdas
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Approach to Carbapenemase Detection in Klebsiella pneumoniae in Routine Diagnostic Laboratories.

Authors:  Rangnekar Aseem; Shalini Shenoy; Suchitra Shenoy Mala; Shrikala Baliga; Agarwal Ashish
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 4.  Companion Animals-An Overlooked and Misdiagnosed Reservoir of Carbapenem Resistance.

Authors:  Joana Moreira da Silva; Juliana Menezes; Cátia Marques; Constança Ferreira Pomba
Journal:  Antibiotics (Basel)       Date:  2022-04-17

5.  Rapid Screening for Carbapenem Resistant Organisms: Current Results and Future Approaches.

Authors:  Shalini Anandan; Sunganya Damodaran; Radha Gopi; Yamuna Devi Bakthavatchalam; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2015-09-01

Review 6.  Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat.

Authors:  Yamuna Devi Bakthavatchalam; Shalini Anandan; Balaji Veeraraghavan
Journal:  J Glob Infect Dis       Date:  2016 Jan-Mar

7.  Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital.

Authors:  Beena Hosdurg Bhaskar; Shalini Shenoy Mulki; Sangeetha Joshi; Ranjeeta Adhikary; Bhavana Malavalli Venkatesh
Journal:  Indian J Crit Care Med       Date:  2019-02

8.  Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.

Authors:  Yumi Park; Qute Choi; Gye Cheol Kwon; Sun Hoe Koo
Journal:  J Clin Lab Anal       Date:  2019-09-20       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.